AIMS: To identify the prognostic factors possibly related to end-stage renal failure development. SUBJECTS AND METHODS: The prognostic factors affecting chronic renal failure progression were analysed in 456 patients who had participated in a formal, multicentre, prospective randomized trial aimed at verifying the role of protein restriction in slowing down or halting the progression of chronic renal failure. The 24-month follow-up foreseen by the protocol was completed by 311 patients and 69 reached an end-point. An inductive analysis on patient survival was made by using the Cox proportional hazard regression model, using a stepwise procedure in order to select only those factors which are significantly associated with survival. For each individual risk factor, a univariate descriptive analysis of survival was performed using the Kaplan-Meier technique. RESULTS:Underlying nephropathy, baseline plasma creatinine, proteinuria, and plasma calcium were all shown to be related to end-stage renal failure onset. Hypertensive patients (mean blood pressure > 107 mmHg) had a worst cumulative renal survival but the degree of proteinuria was even more important as a prognostic factor of renal death than hypertension. The cumulative renal survival of patients whose proteinuria decreased during the trial follow-up was better than those of patients without changes. However, the interaction between baseline lying mean blood pressure and proteinuria was not significant. CONCLUSIONS: Only primary renal disease and proteinuria were related to renal survival, being baseline plasma creatinine confounding factor. By blocking the possible causal role of proteinuria and hypertension, end-stage renal failure could be prevented in a significant percentage of patients.
RCT Entities:
AIMS: To identify the prognostic factors possibly related to end-stage renal failure development. SUBJECTS AND METHODS: The prognostic factors affecting chronic renal failure progression were analysed in 456 patients who had participated in a formal, multicentre, prospective randomized trial aimed at verifying the role of protein restriction in slowing down or halting the progression of chronic renal failure. The 24-month follow-up foreseen by the protocol was completed by 311 patients and 69 reached an end-point. An inductive analysis on patient survival was made by using the Cox proportional hazard regression model, using a stepwise procedure in order to select only those factors which are significantly associated with survival. For each individual risk factor, a univariate descriptive analysis of survival was performed using the Kaplan-Meier technique. RESULTS: Underlying nephropathy, baseline plasma creatinine, proteinuria, and plasma calcium were all shown to be related to end-stage renal failure onset. Hypertensivepatients (mean blood pressure > 107 mmHg) had a worst cumulative renal survival but the degree of proteinuria was even more important as a prognostic factor of renal death than hypertension. The cumulative renal survival of patients whose proteinuria decreased during the trial follow-up was better than those of patients without changes. However, the interaction between baseline lying mean blood pressure and proteinuria was not significant. CONCLUSIONS: Only primary renal disease and proteinuria were related to renal survival, being baseline plasma creatinine confounding factor. By blocking the possible causal role of proteinuria and hypertension, end-stage renal failure could be prevented in a significant percentage of patients.
Authors: Alan R Dyer; Philip Greenland; Paul Elliott; Martha L Daviglus; George Claeys; Hugo Kesteloot; Queenie Chan; Hirotsugu Ueshima; Jeremiah Stamler Journal: Am J Epidemiol Date: 2004-08-01 Impact factor: 4.897
Authors: Sahar A Fathallah-Shaykh; Joseph T Flynn; Christopher B Pierce; Alison G Abraham; Tom D Blydt-Hansen; Susan F Massengill; Marva M Moxey-Mims; Bradley A Warady; Susan L Furth; Craig S Wong Journal: Clin J Am Soc Nephrol Date: 2015-01-29 Impact factor: 8.237
Authors: Shyamal Palit; Michel Chonchol; Alfred K Cheung; James Kaufman; Gerard Smits; Jessica Kendrick Journal: Clin J Am Soc Nephrol Date: 2015-05-15 Impact factor: 8.237
Authors: Mariana A Vasconcelos; Ana Cristina Simões E Silva; Izabella R Gomes; Rafaela A Carvalho; Sergio V Pinheiro; Enrico A Colosimo; Peter Yorgin; Robert H Mak; Eduardo A Oliveira Journal: Pediatr Nephrol Date: 2018-09-08 Impact factor: 3.714
Authors: Cristina M Bouissou Soares; José Silvério S Diniz; Eleonora M Lima; Jose M Penido Silva; Gilce R Oliveira; Monica R Canhestro; Enrico A Colosimo; Ana Cristina Simoes e Silva; Eduardo A Oliveira Journal: Pediatr Nephrol Date: 2008-06-17 Impact factor: 3.714